High-dose flu vaccine use among nursing home residents significantly lowers hospital admissions

Anuja Vaidya (Twitter) - Print  | 

A study, published in The Lancet Respiratory Medicine, examined the effect of a high-dose influenza vaccine — four times the antigens of standard flu vaccines — on hospitalization risk among nursing home residents.

Researchers studied more than 38,000 participants 65 years old and older from 823 nursing homes. They compared the use of two influenza vaccines: one high dose and the other a standard vaccine. The residents received the vaccines in fall of 2013.

The study shows the high-dose vaccine reduced hospitalization for respiratory illness by 12.7 percent compared to the standard-dose vaccine. It also reduced all-cause hospitalizations among residents by 8.5 percent.

"In our study, we estimated that for every 84 individuals receiving the high dose vaccine a person was prevented from being hospitalized during the influenza season," said Stefan Gravenstein, MD, lead author of the study and faculty member at Providence, R.I.-based Warren Alpert Medical School at Brown University; University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine in Cleveland.

More articles on infection control: 
16 multistate Salmonella outbreaks linked to microbiology labs 
Saliva, blood tests comparable for diagnosing hep E, study shows 
Texas health officials warn providers of rise in parasitic infections

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.